Coronary artery bypass grafting ameliorates the decreased plasma adiponectin level in atherosclerotic patients

Creative Commons License

EYİLETEN Z., Yilmaz M. I., KAYA K., AKAR A. R., Kahraman D., Bingol S., ...More

Tohoku Journal of Experimental Medicine, vol.213, no.1, pp.71-77, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 213 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.1620/tjem.213.71
  • Journal Name: Tohoku Journal of Experimental Medicine
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.71-77
  • Keywords: Adiponectin, Coronary artery bypass grafting, Insulin sensitivity, Oxidative stress
  • Lokman Hekim University Affiliated: No


Adiponectin functions as an anti-inflammatbry and anti-atherogenic factor, and the decreased plasma adiponectin is a risk factor for coronary disease. The aim of this study was to determine the changes in plasma levels of adiponectin, a potential parameter for atherosclerosis, in patients underwent surgical revascularization. We included forty patients with atherosclerosis (age, 58 ± 9 years; body mass index [BMI] 26.93 ± 2.3 kg/m2) undergoing coronary artery bypass grafting (CABG). Control group consisted of 40 healthy volunteers, matched for age, gender and BMI (age, 56 ± 6 years; BMI, 26.78 ± 2.3 kg/m2). We measured various parameters, including high sensitive C-reactive protein (hsCRP), homeostasis model assessment-insulin resistance (HOMA-IR) indexes, and adiponectin. The baseline profile of the patients before CABG showed higher levels of serum hsCRP (13.15 ± 2.40 mg/l vs 3.97 ± 1.07mg/l) and HOMA-IR (1.86 ± 0.30 vs 1.26 ± 0.33) and lower plasma adiponectin levels (7.02 ± 2.01 μg/ml vs 25.46 ± 3.9 μg/ml), compared to controls (p < 0.001 for each parameter): Plasma adiponectin level was increased one month after CABG from the baseline level to 8.67 ± 2.05 μg/ml (p < 0.001), although the level was still lower than the control value. Thus, postoperative adiponectin level might be helpful for evaluating the progression of atherosclerosis. Moreover, CABG significantly decreased hsCRP to 7.25 ± 1.89 mg/l and HOMA-IR to 1.59 ± 0.33, although these levels were higher than the controls. These results suggest that CABG decreases the cardiac risk factors in atherosclerotic patients. © 2007 Tohoku University Medical Press.